Correlation Between Sigilon Therapeutics and Kiromic Biopharma
Can any of the company-specific risk be diversified away by investing in both Sigilon Therapeutics and Kiromic Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sigilon Therapeutics and Kiromic Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sigilon Therapeutics and Kiromic Biopharma, you can compare the effects of market volatilities on Sigilon Therapeutics and Kiromic Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sigilon Therapeutics with a short position of Kiromic Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sigilon Therapeutics and Kiromic Biopharma.
Diversification Opportunities for Sigilon Therapeutics and Kiromic Biopharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Sigilon and Kiromic is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Sigilon Therapeutics and Kiromic Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiromic Biopharma and Sigilon Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sigilon Therapeutics are associated (or correlated) with Kiromic Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiromic Biopharma has no effect on the direction of Sigilon Therapeutics i.e., Sigilon Therapeutics and Kiromic Biopharma go up and down completely randomly.
Pair Corralation between Sigilon Therapeutics and Kiromic Biopharma
If you would invest (100.00) in Kiromic Biopharma on November 27, 2024 and sell it today you would earn a total of 100.00 from holding Kiromic Biopharma or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sigilon Therapeutics vs. Kiromic Biopharma
Performance |
| Timeline |
| Sigilon Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
| Kiromic Biopharma |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Sigilon Therapeutics and Kiromic Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sigilon Therapeutics and Kiromic Biopharma
The main advantage of trading using opposite Sigilon Therapeutics and Kiromic Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sigilon Therapeutics position performs unexpectedly, Kiromic Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiromic Biopharma will offset losses from the drop in Kiromic Biopharma's long position.| Sigilon Therapeutics vs. Reviva Pharmaceuticals Holdings | Sigilon Therapeutics vs. ZyVersa Therapeutics | Sigilon Therapeutics vs. Unicycive Therapeutics | Sigilon Therapeutics vs. Apollomics Class A |
| Kiromic Biopharma vs. Quoin Pharmaceuticals Ltd | Kiromic Biopharma vs. Allarity Therapeutics | Kiromic Biopharma vs. Virax Biolabs Group | Kiromic Biopharma vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Stocks Directory Find actively traded stocks across global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |